Clinical Laserthermia Systems receives SEK 8.1 million order from ClearPoint Neuro
Lund, Sverige – Clinical Laserthermia Systems AB (publ) (CLS) today announced it has received an order for ClearPoint Prism™ Neuro Laser Therapy System products from ClearPoint Neuro, Inc (Nasdaq:CLPT). The order has a value of approximately SEK 8.1 million. CLS has a commercial collaboration with ClearPoint Neuro in neurosurgery aimed at developing and commercializing a fully integrated system for MRI image-guided stereotactic laser ablation with very high precision. By offering a solution where both companies' technologies are integrated, the user can identify the target tissue,